Exosome blood test could spot ovarian cancer return when standard tests fail
Diagnosis
Not yet recruiting
This study tests a new blood test called OCS that uses exosome technology to monitor for ovarian cancer recurrence. It focuses on patients whose CA125 levels were normal before initial treatment, making standard monitoring difficult. The trial will enroll 32 women with stage I-IV…
Sponsor: Beihua Kong • Aim: Diagnosis
Last updated Jun 26, 2026 13:38 UTC